Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Gross Profit (2018 - 2025)

Historic Gross Profit for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $10.1 million.

  • Exagen's Gross Profit rose 4432.03% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.1 million, marking a year-over-year increase of 1613.79%. This contributed to the annual value of $33.1 million for FY2024, which is 1241.17% up from last year.
  • According to the latest figures from Q3 2025, Exagen's Gross Profit is $10.1 million, which was up 4432.03% from $10.4 million recorded in Q2 2025.
  • In the past 5 years, Exagen's Gross Profit registered a high of $10.4 million during Q2 2025, and its lowest value of $1.5 million during Q2 2022.
  • For the 5-year period, Exagen's Gross Profit averaged around $7.4 million, with its median value being $7.8 million (2021).
  • Per our database at Business Quant, Exagen's Gross Profit crashed by 7912.85% in 2022 and then skyrocketed by 44325.92% in 2023.
  • Quarter analysis of 5 years shows Exagen's Gross Profit stood at $7.8 million in 2021, then fell by 15.77% to $6.5 million in 2022, then increased by 24.77% to $8.1 million in 2023, then rose by 4.08% to $8.5 million in 2024, then grew by 18.85% to $10.1 million in 2025.
  • Its Gross Profit stands at $10.1 million for Q3 2025, versus $10.4 million for Q2 2025 and $9.1 million for Q1 2025.